Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Sold by Bank of America Corp DE

Bank of America Corp DE cut its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 74.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,473 shares of the company's stock after selling 45,889 shares during the quarter. Bank of America Corp DE owned about 0.06% of Establishment Labs worth $713,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Quarry LP purchased a new position in Establishment Labs in the 4th quarter worth approximately $27,000. KLP Kapitalforvaltning AS acquired a new position in Establishment Labs during the 4th quarter worth approximately $161,000. Hood River Capital Management LLC grew its holdings in Establishment Labs by 236.4% during the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock worth $273,000 after acquiring an additional 4,160 shares in the last quarter. Handelsbanken Fonder AB raised its position in Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Nebula Research & Development LLC purchased a new stake in Establishment Labs in the 4th quarter valued at $440,000. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Stock Down 3.7%

Shares of ESTA stock traded down $1.42 during mid-day trading on Thursday, reaching $37.12. 578,460 shares of the company were exchanged, compared to its average volume of 475,116. The company has a market capitalization of $1.07 billion, a P/E ratio of -14.39 and a beta of 0.74. The business's 50 day simple moving average is $33.79 and its 200 day simple moving average is $37.41. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $52.41.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.13. The firm had revenue of $41.38 million during the quarter, compared to the consensus estimate of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm's revenue was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.58) earnings per share. Research analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Wall Street Analyst Weigh In

ESTA has been the topic of a number of recent analyst reports. BTIG Research initiated coverage on shares of Establishment Labs in a research note on Friday, May 16th. They set a "buy" rating and a $62.00 price target on the stock. Wall Street Zen cut shares of Establishment Labs from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Needham & Company LLC raised shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective on the stock in a research note on Wednesday, May 14th. Finally, Stephens reissued an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. According to MarketBeat, Establishment Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $52.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.